
A | (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian)
。 童心向党,强国有我。10月13日,2024年度抚顺“新时代好少年”先进事迹发布仪式在抚顺广播电视台400平演播大厅举行。
此次活动由抚顺市文明办、市教育局、团市委、市妇联、市关工委共同举办,经过周密组织、层层推荐、严格把关,最终评选产生出86名“新时代好少年”。

B | 他们展现了新时代我市广大少年勤奋好学、向上向善、勇于担当的良好精神风貌,在恪守学生守则、弘扬家庭美德、遵守社会公德等方面为全市少年树立了学习的榜样。

C | 发布仪式上,新时代好少年们向全市少年儿童发出倡议:时刻准备着努力争做有志向、有梦想、爱学习 、爱劳动、懂感恩 懂友善、敢创新、敢奋斗、德智体美劳全面发展的新时代好少年。 希望好少年们不骄不躁,再接再厉,在今后学习和生活中切实发挥好典型示范作用,践行真、善、美,努力争当德智体美劳全面发展的“新时代好少年”! 责任编辑:刘春阳。
Current article:http://ncrsw7q.zhenzongtingrangunhongqiusao.shop/7yco8/20260826/3894.html
Published on:12:45:44
相关阅读 联想新推出的固态移动硬盘架京东:火柴盒尺寸,一体成型金属外壳伊朗正在密谋经济战打击特朗普?凤凰记者:可以打击两个地方恩里克:我们像备战利物浦一样备战阿森纳,巴黎定位球水平也很高食神AI 如何定义你家厨房?Researcher: National Emergency Alert System is Easy To Exploit金价创12年最大单日跌幅,中途休整还是牛市终结?阔别十年风云再起!杰克船长有望回归《加勒比海盗6》铂智3X首次OTA!6月30日起分批次推送
热门文章
科兴制药核心技术人员尚维减持2000股,减持金额4.41万元
50% टैरिफ से धड़ाम हुए ये शेयर, कृषि और कपड़ा कारोबार से जुड़ी कंपिनयों में बिकवाली, क्या आपने लगाया है पैसा
“亚太广播联盟机械人(机器人)大赛”在香港举行
奥克兰免费怀唐伊音乐会火热开启 交通严重拥堵
最新文章
Zaid Khan Clarifies Aryan Khan's Middle Finger Gesture Wasn't Aimed at Fans
泉州获批国家级技术与创新支持中心正式运行
美国大火缺水,“幕后黑手”是富豪夫妻?为 iPhone Ultra 准备好:苹果 iOS 27 代码首现双电芯设计景区“棋”遇记——体彩棋王争霸赛亮相长春肆季南河“彩咖小馆”富临精工:终止德阳川发龙蟒17.5万吨合作,35万吨产线调试
人气排行 梅祖的新音响配件今天发布:官方称为“振翔”奇瑞风云A9L预售15.99万元起 CLTC纯电续航230km 将于7月8日上市【美食美刻】营养“食”光,尽在悦墅—西安未央悦墅幼儿园舌尖上的美食绿色金融提质效 养老金融添活力——建行葫芦岛分行做好五篇大文章推动金融高质量发展瞄准问题“破壁垒” 聚焦需求“强服务”国际精密在几大工业机器人厂商都有合作?中国宝安回应微信支付宝支付了数万亿美元,包裹着砷蜂蜜。骑士媒体人:德罗赞可以在哈登或米切尔下场时成为第二进攻选择
查看所有0条评论>>